» Articles » PMID: 25174025

Medical History, Lifestyle, Family History, and Occupational Risk Factors for Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project

Abstract

Background: Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are two subtypes of non-Hodgkin lymphoma. A number of studies have evaluated associations between risk factors and CLL/SLL risk. However, these associations remain inconsistent or lacked confirmation. This may be due, in part, to the inadequate sample size of CLL/SLL cases.

Methods: We performed a pooled analysis of 2440 CLL/SLL cases and 15186 controls from 13 case-control studies from Europe, North America, and Australia. We evaluated associations of medical history, family history, lifestyle, and occupational risk factors with CLL/SLL risk. Multivariate logistic regression analyses were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).

Results: We confirmed prior inverse associations with any atopic condition and recreational sun exposure. We also confirmed prior elevated associations with usual adult height, hepatitis C virus seropositivity, living or working on a farm, and family history of any hematological malignancy. Novel associations were identified with hairdresser occupation (OR = 1.77, 95% CI = 1.05 to 2.98) and blood transfusion history (OR = 0.79, 95% CI = 0.66 to 0.94). We also found smoking to have modest protective effect (OR = 0.9, 95% CI = 0.81 to 0.99). All exposures showed evidence of independent effects.

Conclusions: We have identified or confirmed several independent risk factors for CLL/SLL supporting a role for genetics (through family history), immune function (through allergy and sun), infection (through hepatitis C virus), and height, and other pathways of immune response. Given that CLL/SLL has more than 30 susceptibility loci identified to date, studies evaluating the interaction among genetic and nongenetic factors are warranted.

Citing Articles

Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry.

de Campos C, McCabe C, Bruins L, OBrien D, Brown S, Tschumper R Blood Cancer J. 2025; 15(1):14.

PMID: 39910036 PMC: 11799526. DOI: 10.1038/s41408-024-01207-3.


Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemia.

Glimelius I, Kleinstern G, Robinson D, Mansouri L, Rostgaard K, Hjalgrim H EJHaem. 2024; 5(5):998-1004.

PMID: 39415908 PMC: 11474300. DOI: 10.1002/jha2.1000.


Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors-A Literature Review.

Halmagyi S, Ungureanu L, Trufin I, Apostu A, Senila S J Clin Med. 2024; 13(15).

PMID: 39124768 PMC: 11313577. DOI: 10.3390/jcm13154501.


Serum levels of B-cell activating factor are associated with a reduced risk of chronic lymphocytic leukemia.

Frost E, Hofmann J, Huang W, Frazer-Abel A, Deane K, Berndt S Blood Cancer J. 2024; 14(1):132.

PMID: 39112445 PMC: 11306784. DOI: 10.1038/s41408-024-01106-7.


Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies.

Luo J, Craver A, Bahl K, Stepniak L, Moore K, King J J Natl Cancer Cent. 2024; 2(4):226-234.

PMID: 39036553 PMC: 11256700. DOI: 10.1016/j.jncc.2022.08.003.


References
1.
Call T, Phyliky R, Noel P, Habermann T, Beard C, OFallon W . Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin Proc. 1994; 69(4):323-8. DOI: 10.1016/s0025-6196(12)62215-0. View

2.
Slager S, Rabe K, Achenbach S, Vachon C, Goldin L, Strom S . Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2010; 117(6):1911-6. PMC: 3056639. DOI: 10.1182/blood-2010-09-308205. View

3.
Pylypchuk R, Schouten L, Goldbohm R, Schouten H, van den Brandt P . Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol. 2009; 170(3):297-307. DOI: 10.1093/aje/kwp123. View

4.
Call T, Norman A, Hanson C, Achenbach S, Kay N, Zent C . Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines. Cancer. 2014; 120(13):2000-5. PMC: 4124730. DOI: 10.1002/cncr.28690. View

5.
Hallek M, Cheson B, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H . Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111(12):5446-56. PMC: 2972576. DOI: 10.1182/blood-2007-06-093906. View